Media — REMAP-CAP Trial

Press releases

Results of interim analyses of Anticoagulation Domain (multi-platform RCT with ATTACC and ACTIV4 trials). Please note that these results are pre-publication and have not been peer-reviewed.

Corticosteroids Improve Survival in Critically Ill COVID-19 Patients (2nd September, 2020)

Podcasts and interviews

Lise Estcourt - convalescent plasma in COVID 19

Sit-down with Rob McSweeney (Critical Care Reviews)

Colin McArthur - REMAP-CAP steroids in COVID-19

Colin McArthur - Hydroxychloroquine in COVID-19

Lennie Derde - taking REMAP-CAP to the wards

Steve Webb - REMAP-CAP

Steve Webb - an introduction to REMAP-CAP

Cameron Green - REMAP-CAP

Introducing REMAP-CAP

REMAP-CAP videos

International Sepsis Forum - REMAP-CAP

REMAP-CAP - Corticosteroids in COVID-19 Results Presentation

REMAP-CAP with Professor Anthony Gordon

Scott Berry - REMAP-CAP Current State Statistical Model

Clinical trial resources

What is an adaptive clinical trial?

What are the benefits of adaptive trial designs?

Response adaptive randomisation

Sample size for adaptive trial designs

What are clinical trials?

What is randomisation?